Wachovia initiates coverage on Synta Pharmaceuticals Corp. (Nasdaq: SNTA) with a Market Perform.

Wachovia analyst says, "Elesclomol's Phase II ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE